Case Report (n=1)
No
Pacing-induced cardiomyopathy can manifest as early as 30 days after pacemaker implantation and can be rapidly reversed with an upgrade to cardiac resynchronization therapy.
Pacing-induced cardiomyopathy (PICM) consists of heart failure (HF) associated with a drop in the left ventricular ejection fraction (LVEF) in the setting of high-burden right ventricular pacing, with presentation that may range from subclinical to severe. Time to manifestation can go from weeks to years after device implantation. Treatment typically consists in an upgrade to a cardiac resynchronisation therapy (CRT) or His bundle pacing (HisP). Several risk factors for PICM have been described and should be considered before pacemaker (PM) implantation, as thorough patient selection for de novo CRT or HisP, may preclude its manifestation. We present the case of an 82-year-old patient presenting with acute congestive HF and new severely reduced LVEF, 30 days following dual chamber PM implantation for high-grade atrioventricular block. Treatment with HF medication and upgrade to a CRT permitted rapid resolution of the symptoms and normalisation of the LVEF at 1-month follow-up.
No takes yet. Share an insight, caveat, or question.
Seydoux et al. (2021) conducted a case report in Pacing-induced cardiomyopathy (n=1). Cardiac resynchronisation therapy (CRT) upgrade was evaluated on Left ventricular ejection fraction (LVEF) and symptom resolution.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: